T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice

Gastroenterology

Volumn 124, Issue 3, 2003, Pages 672-682

  Dohi, Taeko ^a   Fujihashi, Kohtaro ^b   Koga, Toshiya ^b   Shirai, Yuko ^a   Kawamura, Yuki I ^a   Ejima, Chieko ^a   Kato, Rie ^a   Saitoh, Kiyoshi ^a   McGhee, Jerry R ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4 ANTIBODY; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL TRANSFER; CELL TRANSFORMATION; COLITIS; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; GENE ACTIVATION; GENETIC PREDISPOSITION; GOBLET CELL; HYPOALBUMINEMIA; ILEUM; IMMUNE DEFICIENCY; INFLAMMATION; INTESTINE BRUSH BORDER; INTESTINE EPITHELIUM CELL; INTESTINE METAPLASIA; INTESTINE VILLUS ATROPHY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SMALL INTESTINE; TH1 CELL; TH2 CELL; WASTING SYNDROME; WILD TYPE;

EID: 0037373210     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2003.50092     Document Type: Article

References (48)

1. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokines secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
2. + T cells. Annu Rev Immunol 1994;12:635-673.
3. Romagniani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;12:227-275.
4. D'Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D, Telford JL, Romagnani S, Del Prete G. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997;158:962-967.
5. Jaffe JS, James SP, Mullins GE, Braun-Elwert L, Lubensky I, Metcalfe DD. Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma-interferon (gamma-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis. J Clin Immunol 1994;14:299-309.
6. Niessner M, Vold BA. Altered Th1/Th2 cytokine profiles in the intestine mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995;101:428-435.
7. Monteleone G, Biancone L, Marasco R, Morrone G, Marasco O, Luzza R, Pallone F. Interleukin 12 is expressed and actively released by Crohn's disease intestine lamina propria mononuclear cells. Gastroenterology 1997;112:1169-1178.
8. Inoue S, Matsumoto T, Iida M, Mizuno M, Kuroki F, Hoshika K, Shimizu M. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity. Am J Gastroenterol 1999;94:2441-2446.
9. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to interleukin-12 abrogate established experimental colitis in mice. J Exp Med 1995;182:1281-1290.
10. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, McGhee JR. Hapten-induced colitis is associated with colonic patch hypertrophy and Th2-type responses. J Exp Med 1999;189:1169-1179.
11. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998;188:1929-1939.
12. Dohi T, Fujihashi K, Kiyono H, Elson CO, McGhee JR. Mice deficient in Th1-type and Th2-type cytokines develop distinct forms of hapten-induced colitis. Gastroenterology 2000;119:724-733.
13. Dohi T, Rennert PD, Fujihashi K, Kiyono H, Shirai Y, Kawamura YI, Browning JL, McGhee JR. Lymphotoxin-β receptor-immunoglobulin fusion protein inhibits murine colonic patch genesis and Th2-type colitis. J Immunol 2001;167:2781-2790.
14. + T cells. J Exp Med 1993;178:237-244.
15. + T cells induce or protect from chronic intestine inflammation in C.B-17 SCID mice. Int Immunol 1993;5:1461-1471.
16. + T cells. Am J Pathol 1996;148:1503-1515.
17. Hi T cells. J Exp Med 1999;190:1479-1492.
18. De Jong YP, Comiskey M, Kalled SL, Mizoguchi E, Flavell RA, Bhan AK, Terhorst C. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration. Gastroenterology 2000;119:715-723.
19. + T cells. Immunity 1994;1:553-562.
20. + T cells. J Exp Med 1996;183:2669-2674.
21. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin-10 in the function of regulatory T cells that inhibit intestine inflammation. J Exp Med 1999;190:995-1004.
22. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
23. Yamamoto S, Takeda Y, Yamamoto M, Kurazono H, Imaoka K, Fujihashi K, Noda M, Kiyono H, McGhee JR. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J Exp Med 1997;185:1203-1210.
24. Simpson SJ, Shah S, Comiskey M, de Jong YP, Wang B, Mizoguchi E, Bhan AK, Terhorst C. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med 1998;187:1225-1234.
25. Shea-Donohue T, Sullivan C, Finkelman FD, Madden KB, Morris SC, Goldhill J, Pineiro-Carrero V, Urban JF Jr. The role of IL-4 in Heligmosomoides polygyrus-induced alterations in murine intestine epithelial cell function. J Immunol 2001;167:2234-2239.
26. Toi M, Bicknell R, Harris AL. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res 1992;52:275-279.
27. Lahm H, Schnyder B, Wyniger J, Borbenyi Z, Yilmaz A, Car BD, Fischer JR, Givel JC, Ryffel B. Growth inhibition of human colorectal-carcinoma cells by interleukin-4 and expression of functional interleukin-4 receptors. Int J Cancer 1994;59:440-447.
28. Al TA, Spijker R, Pignatelli M, Kirkland SC, Ritter MA. Inhibition of growth and enhancement of differentiation of colorectal carcinoma cell lines by MAb MR6 and IL-4. Int J Cancer 1997;71:605-611.
29. Chang TLY, Peng X, Fu XY. Interleukin-4 mediates cell growth inhibition through activation of stat-1. J Biol Chem 2000;275:10212-10217.
30. Kuperman DB, Schofield B, Willis-Karp M, Grusby MJ. Signal transducer and activator of transcription factor 6 (stat-6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998;187:939-948.
31. Gavett SH, O'Hearn DJ, Karp CL, Patel EA, Schofield BH, Finkelman FD, Wills-Karp M.,Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol 1997;272:L253-L261.
32. Cohn L, Homer RJ, MacLeod H, Mohrs M, Brombacher F, Bottomly K. Th2-induced airway mucus production is dependent on IL-4R-alpha, but not on eosinophils. J Immunol 1999;162:6178-6183.
33. Dabbagh K, Takeyama K, Lee HM, Ueki IF, Lausier JA, Nadel JA. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 1999;162:6233-6237.
34. Suemori S, Lynch-Devaney K, Podolsky DK. Identification and characterization of rat intestine trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci U S A 1991;88:11017-11021.
35. Iwakiri D, Podolsky DK. Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor. Gastroenterology 2001;120:1372-1380.
36. Zeitz M, Ullrich R, Schneider T, Kewenig S, Hohloch K, Riecken EO. HIV/SlV enteropathy. Ann N Y Acad Sci 1998;859:139-148.
37. Groisman GM, Sabo E, Meir A, Polak CS. Enterocyte apoptosis and proliferation are increased in microvillous inclusion disease (familial microvillous atrophy). Hum Pathol 2000;31:1404-1410.
38. Campbell AP, Merrett MN, Kettlewell M, Mortensen NJ, Jewell DP. Expression of colonic antigens by goblet and columnar epithelial cells in ileal pouch mucosa: their association with inflammatory change and faecal stasis. J Clin Pathol 1994;47:834-838.
39. Breese EJ, Kumar P, Farthing MJ, MacDonald TT. Interleukin-2 and interferon-gamma producing cells in the lamina propria in celiac disease (letter). Dig Dis Sci 1994;39:2243.
40. Przemioslo RT, Lundin KE, Sollid LM, Nelufer J, Ciclitira PJ. Histological changes in small bowel mucosa induced by gliadin-sensitive T lymphocytes can be blocked by anti-interferon gamma antibody. Gut 1995;36:874-879.
41. Halttunen T, Maki M. Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestine crypt epithelial cell differentiation. Gastroenterology 1999;116:566-572.
42. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119:234-242.
43. Iqbal N, Oliver JR, Wagner FH, Lazenby AS, Elson CO, Weaver CT. T helper 1 and T helper 2 cells are pathogenic in an antigen-specifc model of colitis. J Exp Med 2002;195:71-84.
44. Mizoguchi A, Mizoguchi E, Chiba C, Spiekermann GM, Tonegawa S, Nagler-Anderson C, Bhan AK. Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 1996;183:847-856.
45. Iijima H, Takahashi I, Kishi D, Kim JK, Kawano S, Hori M, Kiyono H. Alteration of interleukin-4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor chain-α-deficient mice. J Exp Med 1999;190:607-616.
46. Mizoguchi A, Mizoguchi E, Bhan AK. The critical role of interleukin-4 but not interferon gamma in the pathogenesis of colitis in T cell receptor-α mutant mice. Gastroentelogy 1999;116:320-326.
47. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75:275-282.
48. Halttunen T, Maki M. Serum immunoglobulin A from patients with celiac disease inhibits human T 84 intestine crypt epithelial cell differentiation. Gastroenterology 1999;116:566-572.